3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
10
Breast Neoplasms
9
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
5
Rectal Neoplasms
4
Lung Neoplasms
4
Head and Neck Neoplasms
4
Adenomatous Polyposis Coli
4
Sarcoma
3
Glioblastoma
3
Central Nervous System Neoplasms
3
Paranasal Sinus Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Gliosarcoma
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Tobacco Use Disorder
1
Stomatitis
1
Smoldering Multiple Myeloma
1
Smoking
1
Recurrence
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Precancerous Conditions
1
Interventions
Irinotecan
3
pembrolizumab
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
trifluridine tipiracil drug combination
1
pralsetinib
1
napabucasin
1
alectinib
1
S-1 plus cisplatin
1
Levoleucovorin
1
KRN-330
1
Indocyanine Green
1
Imatinib Mesylate
1
Fluorescein
1
Docetaxel
1
Cyclophosphamide
1
Calcium Dobesilate
1
Bupivacaine
1
Bevacizumab
1
Ascorbic Acid
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Gastrointestinal Diseases
×
Celecoxib
×
Clear all
No trials found.